The replication of the association of the rs9355610 within 6p27 with Graves’ disease

References

• Jacobson, D. L., S. J. Gange, N. R. Rose, and N. M. Graham. 1997. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin. Immunol. Immunopathol. 84: 223–243
   PubMedGoogle Scholar
• Hollowell, J. G., N. W. Staehling, W. D. Flanders, et al. 2002. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab. 87: 489–499
   PubMed Web of Science ®Google Scholar
• Davies, T. F. 2000. Graves' diseases: Pathogenesis. In Werner and Ingbar's the Thyroid: A Fundamental and Clinical Text, L. E. Braverman and R. D. Utiger, eds. Lippincott-Raven, Philadelphia, PA. p. 518–530
   Google Scholar
• Weetman, A. P. 1996. Chronic autoimmune thyroiditis. In Werner and Ingbar's the Thyroid: A Fundamental and Clinical Text, L. E. Braverman and R. D. Utige, Lippincott-Raven, Philadelphia, PA. p. 738–748
   Google Scholar
• Tomer, Y. 1997. Anti-thyroglobulin autoantibodies in autoimmune thyroid diseases: Cross-reactive or pathogenic? Clin. Immunol. Immunopathol. 82: 3–11
   PubMedGoogle Scholar
• Tomer, Y., and T. F. Davies. 2003. Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr. Rev. 24: 694–717
   PubMed Web of Science ®Google Scholar
• Tomer, Y., and T. F. Davies. 1993. Infection, thyroid disease and autoimmunity. Endocr. Rev. 14: 107–120
   PubMed Web of Science ®Google Scholar
• Brix, T. H., P. S. Hansen, K. O. Kyvik, and L. Hegedus. 2000. Cigarette smoking and risk of clinically overt thyroid disease: A population-based twin case-control study. Arch. Intern. Med. 160: 661–666
   PubMedGoogle Scholar
• Stenszky, V., L. Kozma, C. Balazs, S. Rochlits, et al. 1985. The genetics of Graves' disease: HLA and disease susceptibility. J. Clin. Endocrinol. Metab. 61: 735–740
   PubMed Web of Science ®Google Scholar
• Mangklabruks, A., N. Cox, and L. J. DeGroot. 1991. Genetic factors in autoimmune thyroid disease analyzed by restriction fragment length polymorphisms of candidate genes. J. Clin. Endocrinol. Metab. 73: 236–244
   PubMed Web of Science ®Google Scholar
• Heward, J. M., A. Allahabadia, J. Daykin, et al. 1998. Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and Graves' disease: replication using a population case control and family-based study. J. Clin. Endocrinol. Metab. 83: 3394–3397
   PubMed Web of Science ®Google Scholar
• Ban, Y., and Y. Tomer. 2003. The contribution of immune regulatory and thyroid specific genes to the etiology of Graves' and Hashimoto's diseases. Autoimmunity. 36: 367–379
   PubMed Web of Science ®Google Scholar
• Yanagawa, T., Y. Hidaka, V. Guimaraes, et al. 1995. CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J. Clin. Endocrinol. Metab. 80: 41–45
   PubMed Web of Science ®Google Scholar
• Tomer, Y., E. Concepcion, and D. A. Greenberg. 2002. A C/T single nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Thyroid. 12: 1129–1135
   PubMed Web of Science ®Google Scholar
• Brand, O. J., C. E. Lowe, J. M. Heward, et al. 2007. Association of the interleukin-2 receptor alpha (IL-2Ralpha)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs. Clin. Endocrinol. (Oxf.). 66: 508–512
   PubMed Web of Science ®Google Scholar
• Tomer, Y., D. A. Greenberg, E. Concepcion, et al. 2002. Thyroglobulin is a thyroid specific gene for the familial autoimmune thyroid diseases. J. Clin. Endocrinol. Metab. 87: 404–407
   PubMed Web of Science ®Google Scholar
• Dechairo, B. M., D. Zabaneh, J. Collins, et al. 2005. Association of the TSHR gene with Graves' disease: the first disease specific locus. Eur. J. Hum. Genet. 13: 1223–1230
   PubMed Web of Science ®Google Scholar
• Hiratani, H., D. W. Bowden, S. Ikegami, et al. 2005. Multiple SNPs in intron 7 of thyrotropin receptor are associated with Graves' disease. J. Clin. Endocrinol. Metab. 90: 2898–2903
   PubMed Web of Science ®Google Scholar
• Chu, X., C. M. Pan, S. X. Zhao, et al. 2011. A genome-wide association study identifies two new risk loci for Graves’ disease. Nat. Genet. 43: 897–901
   PubMed Web of Science ®Google Scholar
• Werner, S. C. 1977. Modification of the classification of the eye changes of Graves’ disease: recommendation of the Ad Hoc Committee of the American Thyroid Association. J. Clin. Endocrinol. Metab. 44: 203–204
   PubMed Web of Science ®Google Scholar
• Dynacom website. 2012. Available from: http://www.dynacom.co.jp/e/products/package/snpalyze/. Accessed 2012 November 18
   Google Scholar
• Woolf, B. 1955. On estimating the relation between blood group and disease. Ann. Hum. Genet. 19: 251–253
   PubMed Web of Science ®Google Scholar
• Bahn, R. 2003. Pathophysiology of Graves’ Ophthalmopathy: The cycle of disease. J. Clin. Endocrinol. Metab. 88: 1939–1946
   PubMed Web of Science ®Google Scholar
• Kochi, Y., Y. Okada, A. Suzuki, et al. 2010. A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility. Nat. Genet. 42: 515–519
   PubMed Web of Science ®Google Scholar
• Quan, C., Y. Q. Ren, L. H. Xiang, et al. 2010. Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC. Nat. Genet. 42: 614–618
   PubMed Web of Science ®Google Scholar
• Birlea, S. A., K. Gowan, P. R. Fain, and R. A. Spritz. 2010. Genome-wide association study of generalized vitiligo in an isolated European founder population identifies SMOC2, in close proximity to IDDM8. J. Invest. Dermatol. 130: 798–803
   PubMed Web of Science ®Google Scholar
• Bradfield, J. P., H. Q. Qu, K. Wang, et al. 2011. A genome-wide meta-analysis of six type 1 diabetes cohorts identifies multiple associated loci. PLoS Genet. 7: e1002293
   PubMed Web of Science ®Google Scholar
• Acquati, F., L. Possati, L. Ferrante, et al. 2005. Tumor and metastasis suppression by the human RNASET2 gene. Int. J. Oncol. 26: 1159–1168
   PubMed Web of Science ®Google Scholar
• Liu, J., V. K. Zhawar, G. Kaur, et al. 2010. Chromosome 6 encoded RNaseT2 protein is a cell growth regulator. J. Cell Mol. Med. 14: 1146–1155
   PubMed Web of Science ®Google Scholar
• Everts, B., G. Perona-Wright, H. H. Smits, et al. 2009. Omega-1, a glycoprotein secreted by Schistosoma mansoni eggs, drives Th2 responses. J. Exp. Med. 206: 1673–1680
   PubMed Web of Science ®Google Scholar
• Steinfelder, S., J. F. Andersen, J. L. Cannons, et al. 2009. The major component in schistosome eggs responsible for conditioning dendritic cells for T2 polarization is a T2 ribonuclease (omega-1). J. Exp. Med. 206: 1681–1690
   PubMed Web of Science ®Google Scholar
• Dixon, A. L., L. Liang, M. F. Moffatt, et al. 2007. A genome-wide association study of global gene expression. Nat. Genet. 39: 1202–1207
   PubMed Web of Science ®Google Scholar
• Barrett, J. C., S. Hansoul, D. L. Nicolae, et al. 2008. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease. Nat. Genet. 40: 955–962
   PubMed Web of Science ®Google Scholar
• Stahl, E. A., S. Raychaudhuri, E. F. Remmers, et al. 2010. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat. Genet. 42: 508–514
   PubMed Web of Science ®Google Scholar
• Jin, Y., S. A. Birlea, P. R. Fain, et al. 2010. Common variants in FOXP1 are associated with generalized vitiligo. Nat. Genet. 42: 576–578
   PubMed Web of Science ®Google Scholar
• Szymanski, K., T. Bednarczuk, P. Krajewski, and R. Ploski. 2012. The replication of the association of the rs6832151 within chromosomal band 4p14 with Graves’ disease in a Polish Caucasian population. Tissue Antigens. 79: 380–383
   PubMedGoogle Scholar